ARTICLE | Company News
Breakthrough designation for Pfizer's meningococcal B vaccine
March 20, 2014 11:58 PM UTC
Pfizer Inc. (NYSE:PFE) said FDA granted breakthrough therapy designation for bivalent rLP2086 to prevent meningococcal B disease. The designation was based in part on data from two Phase II trials in ...